EMEA-002298-PIP01-17-M04
Key facts
| Invented name |
Evkeeza
|
| Active substance |
Evinacumab
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0394/2022
|
| PIP number |
EMEA-002298-PIP01-17-M04
|
| Pharmaceutical form(s) |
Concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of elevated cholesterol
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Ultragenyx Germany GmbH
E-mail: medinfo@ultragenyx.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|